Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Regular, moderate coffee consumption may reduce risk of type 2 diabetes

Recent scientific evidence has consistently linked regular, moderate coffee consumption with a reduced risk of developing type 2 diabetes. An update of this research will be presented by experts working in this field at the World Congress on Prevention of Diabetes and Its Complications (WCPD), taking place on 11-14 November in Madrid, Spain.

9 Nov 2012

Diabetic foot complication risk highlighted in men

Men should be considered for aggressive treatment for foot complications associated with diabetes, such as ulceration and amputation, say researchers.

8 Nov 2012

BMI may not be best measure for estimation of cancer risk

A study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that body mass index (BMI)-the most commonly used weight-for-height formula for estimating fatness-may not be the best measure for estimating disease risk, and particularly the risk of certain types of cancer. The study was published today in the online edition of the American Journal of Epidemiology.

8 Nov 2012

Metformin more effective than sulfonylurea in controlling type 2 diabetes

A Vanderbilt study examining the impact of the two most commonly prescribed oral diabetes medications on the risk for heart attack, stroke and death has found the drug metformin has benefits over sulfonylurea drugs.

8 Nov 2012

Link between SFRP4 protein and risk of type 2 diabetes

When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.

7 Nov 2012

Weight loss can help improve quality of sleep among obese people

Weight loss, whether it's from dietary changes alone or from diet combined with exercise, can help improve the quality of sleep among people who are overweight or obese, according to a new study by Johns Hopkins researchers.

7 Nov 2012

Results from liraglutide and exenatide head-to-head comparison trial on type 2 diabetes

A direct, head-to-head comparison of two of the newer treatments available for type 2 diabetes yielded mixed results.

7 Nov 2012

Lexicon announces data from LX4211 Phase 2b trial on type 2 diabetes

Lexicon Pharmaceuticals, Inc. announced that data from the Phase 2b clinical trial of LX4211 are being presented today as a Clinical Sciences Special Report in the Emerging Therapeutics for Diabetes and Dyslipidemia section of the American Heart Association (AHA) Scientific Sessions Conference held in Los Angeles, California.

7 Nov 2012

Traditional CV risk factors linked to peripheral artery disease

Smoking, Type 2 diabetes, hypertension, and hypercholesterolemia are significantly associated with the risk for clinically significant peripheral artery disease in men, with each additional factor doubling the risk, conclude US and Dutch researchers.

6 Nov 2012

Traditional CV risk factors linked to peripheral artery disease

5 Nov 2012

Health Net provides public with information on how to help prevent diabetes

With November being American Diabetes Month, Health Net, Inc. is providing the public with information on how to help prevent diabetes and how to help live an active lifestyle after being diagnosed with the condition.

3 Nov 2012

Malaysia hopes to solve nutrition transition problem

With health problems like obesity and diabetes on the rise due to changing diets in emerging economies, Malaysia is forging new linkages between domestic and international scientists and institutions in hopes of mitigating the problem.

3 Nov 2012

Australia's Generation X on the path to become more obese than baby boomers

New research from the University of Adelaide shows that Australia's Generation X is already on the path to becoming more obese than their baby boomer predecessors.

2 Nov 2012

TransTech Pharma to complete TTP054 Phase 2 trial on type 2 diabetes

TransTech Pharma, Inc., announced today that recruitment of patients for its recently initiated, multi-center Phase 2 clinical trial of TTP054 in type 2 diabetics, is exceeding expectations with initial top line results available in early 2013. The 90-day proof of concept study is being conducted in type 2 diabetics not well controlled with approved oral anti-diabetic agents.

2 Nov 2012

Benaroya Research Institute at Virginia Mason wins Grand Challenges Explorations grant

Benaroya Research Institute at Virginia Mason (BRI) announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.

1 Nov 2012

Nabilone shows promise in treating diabetic neuropathy

A study from the University of Calgary's Hotchkiss Brain Institute shows there is evidence to support a new drug therapy called nabilone to treat diabetic neuropathy, or nerve pain.

31 Oct 2012

Positive interim data from XBiotech monoclonal antibody Phase II study for type 2 diabetes

XBiotech, a privately held biotechnology company, announced positive interim analysis results today from a Phase II study using a True Human monoclonal antibody (MABp1) in patients with type 2 diabetes. Results from this study continue to reinforce the role of IL-1α as a master regulator of chronic inflammation in multiple disease states, and the therapeutic benefits of neutralizing antibodies produced from the XBiotech platform.

29 Oct 2012

Peer mentoring in schools can increase kids' physical activity levels

Using peer mentors to enhance school-day physical activity in elementary aged students has been given an A+ from Nova Scotia researchers.

29 Oct 2012

New findings on early treatment of ADHD patients presented at AACAP 2012 conference

Mayo Clinic researchers are presenting new findings on the early treatment of child and adolescent attention deficit hyperactivity disorder this week at the American Academy of Childhood and Adolescent Psychiatry annual meeting in San Francisco.

29 Oct 2012

Results of diabetes management program to be presented at Canadian Cardiovascular Congress

In Canada alone, almost 2 million people are known to be living with diabetes. And around a million more have the disease but are not aware of that fact, and have not been given the tools they need to control their blood sugar and safeguard their health.

29 Oct 2012